Resources Repository
-
ArticlePublication 1964Epidemics and Rumors
Goffman and Newill directed attention to the analogy between the spreading of an infectious disease …
Goffman and Newill directed attention to the analogy between the spreading of an infectious disease and the dissemination of information. This article examines the spreading of a rumor from the point of view of mathematical epidemiology and briefly reports on work to be published in detail elsewhere. Authors emphasize that a mathematical model for the spreading of rumors can be constructed in a number of different ways, depending on the mechanism postulated to describe the…
Preferences/Values | Infectious Diseases | Culture/Society | Health/Medicine | Science/Technology | Global -
ArticlePublication 2020COVID-19 Infodemic: A New Front for Information Professionals
COVID-19 emerged from Wuhan, China and has spread in 213 countries, areas, or territories around …
COVID-19 emerged from Wuhan, China and has spread in 213 countries, areas, or territories around the globe, with nearly 144,683 deaths worldwide as-of April 18, 2020. In the wake of the COVID-19 pandemic, we have witnessed a massive infodemic with the public being bombarded with vast quantities of information, much of which is not scientifically correct. Fighting fake news is now the new front in the COVID-19 battle. This article comments on the role of…
Preferences/Values | Infectious Diseases | Social Determinants | Policy/Regulation | Culture/Society | Health/Medicine | Science/Technology | Global -
ArticlePublication 2021Correct COVID-19 Vaccine Misinformation: Lancet Commission on COVID-19 Vaccines & Therapeutics Task Force Members
This brief “primer” assists healthcare providers in correcting a growing body of misinformation surrounding COVID-19 …
This brief “primer” assists healthcare providers in correcting a growing body of misinformation surrounding COVID-19 vaccines. In 2020, up to one-third or more of people surveyed both globally and in the U.S. indicated they might refuse the first COVID-19 vaccines when released through emergency use authorization (EUA). Their rationale included questions about vaccine efficacy, potential side effects, or speeding through regulatory approval processes. Even among healthcare workers, high rates of COVID-19 vaccine hesitancy were noted.…
Preferences/Values | Infectious Diseases | Social Determinants | Policy/Regulation | Global Governance | Culture/Society | Health/Medicine | Science/Technology | Global -
ArticlePublication 2021Anti-Vaccination Infodemic on Social Media: A Behavioral Analysis
Vaccinations are without doubt one of the greatest achievements of modern medicine, and there is …
Vaccinations are without doubt one of the greatest achievements of modern medicine, and there is hope that they can constitute a solution to halt the ongoing COVID-19 pandemic. However, the anti-vaccination movement is currently on the rise, spreading online misinformation about vaccine safety and causing a worrying reduction in vaccination rates worldwide. In this historical time, it is imperative to understand the reasons of vaccine hesitancy, and to find effective strategies to dismantle the rhetoric…
Preferences/Values | Infectious Diseases | Social Determinants | Culture/Society | Government/Law | Health/Medicine | Science/Technology | North America -
ArticlePublication 2018Addressing Health-Related Misinformation on Social Media
Policy makers and the social media industry grapple with the challenge of curbing fake news, …
Policy makers and the social media industry grapple with the challenge of curbing fake news, disinformation, and hate speech; and the field of medicine is similarly confronted with the spread of false, inaccurate, or incomplete health information. This viewpoint argues that medical, public health, social science, and computer science experts must begin working together via interdisciplinary research to address health misinformation on social media, with a focus on the following four themes: (1) defining the…
Decision Psychology | Social Determinants | Culture/Society | Health/Medicine | Science/Technology | North America -
Resource PackPublication, Teaching Resource 2021Resource Pack: Risk, Economics, and Decisions
This resource pack, curated by the Center for Health Decision Science, includes articles from the …
This resource pack, curated by the Center for Health Decision Science, includes articles from the Risk Analysis special issue “Risk Assessment, Economic Evaluation, and Decisions” honoring Professor John Evans. The special issue was guest edited by CHDS’ Deputy Director Lisa A. Robinson and builds upon a 2019 workshop organized by Ms. Robinson and CHDS faculty James K. Hammitt. Articles include: James K. Hammitt, Lisa A. Robinson. Introduction to Special Issue on Risk Assessment,…
Risk Analysis | Decision Analysis | Policy/Regulation -
ArticlePublication 2020Testing for SARS-CoV-2 Antibodies
Antibody testing can determine previous exposure to SARS-CoV-2 virus. Recently, the UK government has made …
Antibody testing can determine previous exposure to SARS-CoV-2 virus. Recently, the UK government has made antibody testing available to anyone wanting it, even if there is no clinical indication. The purpose of this article is to provide guidance for when to consider antibody testing in individuals with and without symptoms suggestive of current or past SARS-CoV-2 infection. Key points made by the authors include: (1) antibody testing is likely to be most useful 2 weeks…
Probability/Bayes | Test Performance | Technology Assessment | Infectious Diseases | Clinical Care | Health/Medicine -
ToolInteractive 2020COVID-19 Antibody Tests: Calculator for Interpreting Test Results
Antibody testing can determine previous exposure to SARS-CoV-2 virus. This interactive calculator, linked to the article …
Antibody testing can determine previous exposure to SARS-CoV-2 virus. This interactive calculator, linked to the article below* on antibody testing for SARS-CoV-2 virus, allows users to vary the prior probability of infection, the sensitivity of SARS-CoV-2 antibody testing, and the specificity of SARS-CoV-2 antibody testing. Key points made in the article accompanying the interactive include: (1) antibody testing is likely to be most useful 2 weeks after infection, (2) sensitivity and specificity will vary over time and…
Probability/Bayes | Test Performance | Technology Assessment | Infectious Diseases | Clinical Care | Health/Medicine | Science/Technology -
EditorialPublication 2020Waiting for Certainty on COVID-19 Antibody Tests — At What Cost?
This perspective anticipates the availability of serologic antibody testing and considers its potential usefulness in mitigation …
This perspective anticipates the availability of serologic antibody testing and considers its potential usefulness in mitigation policy to reduce COVID-19 transmission. For example: Could we screen for serologic antibodies as a proxy for possible immunity and identify people who could return to the workplace with less severe mitigation measures? The authors acknowledge the uncertainties raised by many policy actors, including the WHO, such as, "Do antibodies confer immunity and, if so, for how long? How accurate is…
Probability/Bayes | Test Performance | Technology Assessment | Infectious Diseases | Health Systems | Policy/Regulation | Government/Law | Health/Medicine | Global | North America